Morbidity and mortality after stroke--eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)

Stroke. 2006 Feb;37(2):335-6; author reply 338. doi: 10.1161/01.STR.0000199659.31103.d2. Epub 2006 Jan 5.
No abstract available

Publication types

  • Comment
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Acrylates / pharmacology*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Cardiovascular Diseases / pathology
  • Data Interpretation, Statistical
  • Diuretics / pharmacology
  • Humans
  • Imidazoles / pharmacology*
  • Internal Medicine / methods
  • Ischemic Attack, Transient / drug therapy
  • Ischemic Attack, Transient / mortality*
  • Ischemic Attack, Transient / pathology*
  • Morbidity
  • Neurology / methods
  • Nitrendipine / pharmacology*
  • Prospective Studies
  • Stroke / drug therapy
  • Stroke / mortality*
  • Stroke / pathology*
  • Thiophenes / pharmacology*

Substances

  • Acrylates
  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Imidazoles
  • Thiophenes
  • eprosartan
  • Nitrendipine